Literature DB >> 9353621

Aspirin therapy in diabetes. American Diabetes Association.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9353621     DOI： 10.2337/diacare.20.11.1772

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  9 in total

Review 1.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  An intensive nurse-led, multi-interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care.

Authors:  J MacMahon Tone; A Agha; M Sherlock; F Finucane; W Tormey; C J Thompson
Journal:  Ir J Med Sci       Date:  2009-04-15       Impact factor: 1.568

3.  PPAR-γ receptor agonists-a review of their role in diabetic management in Trinidad and Tobago.

Authors:  Steve Ian Smith
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

4.  [Diabetes, heart surgery and the peripheral arteries].

Authors:  C Diehm; H Lawall
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

5.  Naturopathic medicine and type 2 diabetes: a retrospective analysis from an academic clinic.

Authors:  Ryan Bradley; Erica B Oberg
Journal:  Altern Med Rev       Date:  2006-03

6.  An electronic prompt in dispensing software to promote clinical interventions by community pharmacists: a randomized controlled trial.

Authors:  James F Reeve; Peter C Tenni; Gregory M Peterson
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

Review 7.  The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Authors:  Robert L Frye; Malcolm R Bell; Hartzell V Schaff; Richard Holubkov; Katherine M Detre
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

8.  Prevalence of antiplatelet therapy in patients with diabetes.

Authors:  Shaun R Miller; Benjamin Littenberg; Charles D MacLean
Journal:  Cardiovasc Diabetol       Date:  2005-12-01       Impact factor: 9.951

Review 9.  Aspirin for primary prevention: Is this the end of the road?

Authors:  Aayush Kumar Singal; Ganesan Karthikeyan
Journal:  Indian Heart J       Date:  2019-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.